UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022842
Receipt number R000026326
Scientific Title Confirmation trial for body fat-reducing effect of a beverage containing the lactic acid bacterial strain CP1563 - A randomized, double-blind, placebo-controlled parallel group trial -
Date of disclosure of the study information 2016/06/24
Last modified on 2017/12/25 10:55:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Confirmation trial for body fat-reducing effect of a beverage containing the lactic acid bacterial strain CP1563 - A randomized, double-blind, placebo-controlled parallel group trial -

Acronym

Trial for body fat-reducing effect of CP1563

Scientific Title

Confirmation trial for body fat-reducing effect of a beverage containing the lactic acid bacterial strain CP1563 - A randomized, double-blind, placebo-controlled parallel group trial -

Scientific Title:Acronym

Trial for body fat-reducing effect of CP1563

Region

Japan


Condition

Condition

Healthy adults with BMI values over 23 but less than 30

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Effects of a lactic beverage containing CP1563 on the reduction of body fat, visceral fat and subcutaneous fat

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluate the effects of a beverage containing CP1563 on fat area determined by CT through the 18-week intervention period

Key secondary outcomes

Evaluate the effects of a beverage containing CP1563 on lipid and sugar metabolisms through the 18-week intervention period


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Daily intakes of a beverage containing CP1563 for 18 weeks

Interventions/Control_2

Daily intakes of a beverage without CP1563 for 18 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1. Subjects whose BMI values are over 23 but less than 30 (subjects of high normal and obesity class I)
2. Subjects whose visceral fat area is around 100 cm2

Key exclusion criteria

1. Persons who take drugs for adiposity, hypertension and dyslipidemia
2. Persons who cannot give up the intake of possible supplements which may affect the status of fat, blood pressure and plasma lipids
3. Persons who cannot terminate the consumption of foods containing large number of lactic acid bacteria during the trial

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Mamoru Oki

Organization

Incorporated Medical Association Seishukai

Division name

Seishukai Clinic

Zip code


Address

3-18-5 Matsugatani, Taito-ku, Tokyo

TEL

03-3847-8866

Email

mamoru.oki@seishukai.clinic.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshika Komori

Organization

KSO Co., Ltd

Division name

Chairperson

Zip code


Address

1-9-7 Shibaura, Minato-ku, Tokyo

TEL

03-3452-7733

Homepage URL


Email

yoshi@kso.co.jp


Sponsor or person

Institute

Asahi Group Holdings, Ltd

Institute

Department

Personal name



Funding Source

Organization

Asahi Group Holdings, Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 06 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

As results of having analyzed the data obtained in the trial using an analysis of covariance for repeated measures, significant differences in both total body fat and visceral fat areas between both groups were recognized.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2016 Year 06 Month 23 Day

Date of IRB


Anticipated trial start date

2016 Year 06 Month 25 Day

Last follow-up date

2017 Year 01 Month 29 Day

Date of closure to data entry

2017 Year 02 Month 17 Day

Date trial data considered complete

2017 Year 04 Month 10 Day

Date analysis concluded

2017 Year 10 Month 31 Day


Other

Other related information

In the stratified analyses using an analysis of covariance for repeated measures, significant differences in both total body fat and visceral fat areas between both groups were also recognized.in subjects who have the initial visceral fat area less than 100cm2.


Management information

Registered date

2016 Year 06 Month 22 Day

Last modified on

2017 Year 12 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026326


Research Plan
Registered date File name
2017/12/25 CPS-008-01試験実施計画書20160620.doc

Research case data specifications
Registered date File name

Research case data
Registered date File name